C12N 2770/32611
Poliovirus
C12N2770/32611 (Poliovirus) appears on 241 US grants and 248 published applications in this corpus.
Search patents in C12N- Granted patents
- 241
- Published applications
- 248
- Assignees
- 147
- Inventors
- 512
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 7 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 7 | 0 |
| 1995 | 0 | 0 |
| 1996 | 7 | 0 |
| 1997 | 10 | 0 |
| 1998 | 6 | 0 |
| 1999 | 9 | 0 |
| 2000 | 18 | 0 |
| 2001 | 6 | 1 |
| 2002 | 6 | 5 |
| 2003 | 4 | 18 |
| 2004 | 7 | 7 |
| 2005 | 3 | 5 |
| 2006 | 4 | 9 |
| 2007 | 5 | 5 |
| 2008 | 1 | 8 |
| 2009 | 1 | 5 |
| 2010 | 2 | 15 |
| 2011 | 6 | 9 |
| 2012 | 3 | 3 |
| 2013 | 9 | 15 |
| 2014 | 7 | 12 |
| 2015 | 5 | 18 |
| 2016 | 11 | 9 |
| 2017 | 5 | 12 |
| 2018 | 16 | 13 |
| 2019 | 15 | 20 |
| 2020 | 7 | 11 |
| 2021 | 8 | 13 |
| 2022 | 8 | 12 |
| 2023 | 4 | 6 |
| 2024 | 7 | 10 |
| 2025 | 4 | 2 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/32634Use of virus or viral component as vaccineIndexing code147
- C12N 2770/32622New viral proteins or individual genes, new structural or functional aspects ofIndexing code65
- C12N 2770/32661Methods of inactivation or attenuationIndexing code32
- C12N 2770/32641Use of virus, viral particle or viral elements as a vectorIndexing code27
- C12N 2770/32651Methods of production or purification of viral materialIndexing code21
- C12N 2770/32632Use of virus as therapeutic agent, other than vaccineIndexing code13
- C12N 2770/32671Demonstrated in vivo effectIndexing code12
- C12N 2770/32621Viruses as suchIndexing code8
Recent patents
- Micromolded or 3-D printed pulsatile release vaccine formulations12 May 2026US 12,622,963 B2Massachusetts Institute of Technology
- Viral vector24 Jun 2025US 12,337,030 B2Valo Therapeutics Oy
- Adapted enterovirus D68 that propagates to high titer in vero cells6 May 2025US 12,290,555 B2Bharat Biotech International Limited
- Liquid six combined vaccine composition8 Apr 2025US 12,268,738 B2KM Biologics Co., Ltd.
- Methods for the prophylaxis and treatment of COVID and COVID-194 Mar 2025US 12,239,629 B2
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Rna vectors with hairpin-like inserts17 Sep 2026US 2026/0275366 A1
- Micromolded or 3-d printed pulsatile release vaccine formulations6 Aug 2026US 2026/0224697 A1Massachusetts Institute of Technology
- Pentameric toxin protein-based target protein fusion pentamer producing platform using viral nucleocapsid2 Jul 2026US 2026/0184745 A1University-Industry Foundation, Yonsei University
- Systems and methods to produce b cells that express selected antibodies and gene products19 Feb 2026US 2026/0048123 A1Fred Hutchinson Cancer Center
Most cited
By later US patents
- Method for processing and preserving collagen-based tissues for transplantation610US 5,336,616 ALifeCell Corporation · 1994
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Method of cryopreserving a suspension of biological material150US 5,364,756 ALifeCell Corporation · 1994
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996